BioArctic AB will publish its second quarter financial report for April to June 2026 on August 26, 2026, at 8:00 a.m. CEST. The company will hold a webcast at 9:30 a.m. CEST the same day, where CEO Gunilla Osswald and CFO Anders Martin-Löf will present the results and answer questions. Investors and media can join the webcast or teleconference to learn about the company's performance and outlook. BioArctic is known for its innovative treatments for neurodegenerative diseases, including the Alzheimer's drug Leqembi®.
Walmart dominates U.S. grocery spending with a 20.8% share, far ahead of Amazon's 2.9%, securing frequent shopper visits. However, Amazon leads in broader retail categories like electronics, apparel, and home goods, capturing 9.3% of total U.S. retai...
Playtika is successfully transforming its business by increasing direct-to-consumer (D2C) sales, which now account for 39.3% of its revenue. This shift has driven a significant margin expansion, with adjusted EBITDA margin rising from 16.8% in Q1 to ...
Kaito AI's new browser extension, Kaito Pulse, launched on August 18, has been scrutinized after an analyst's source-code review revealed it fingerprints devices and tracks detailed user activity on X, including posts viewed, clicks, searches, and bo...
Chainlink (LINK) has risen to $9.64, its highest since May 27, driven by a 15.1% weekly gain and strong whale accumulation with unique holders reaching a record 3.96 million. Despite trading 81.89% below its 2021 peak, analysts see LINK at a generati...
Hyperliquid's native token HYPE is trading around $59.37, showing strong technical support and bullish momentum. A major whale withdrew 57,000 tokens from Coinbase, signaling long-term accumulation, while derivatives trading surged nearly 19%. The Hy...
